Imagine having an infection that used to be easy to treat, but the usual medicine no longer works. That is the basic idea behind antimicrobial resistance, often called AMR. It is one of the most important medical problems of the coming decades because modern medicine depends heavily on effective antimicrobials.
Antibiotics do not “make bacteria stronger” in the way people sometimes imagine. Instead, bacteria can change over time. When antibiotics kill susceptible bacteria, resistant bacteria may survive and multiply. Resistance can also spread between bacteria through genetic material. The more opportunities bacteria have to encounter antibiotics, especially when medicines are misused or overused, the greater the
pressure for resistance.
AMR is broader than antibiotic resistance. Antimicrobial medicines include antibiotics, antivirals, antifungals and antiparasitic drugs. Resistance can develop across these categories.
Why should an ordinary person care? Because antibiotics are not only used for routine infections. They are essential for surgery, cancer treatment, organ transplantation, intensive care and many procedures that would otherwise carry a much higher infection risk.
The World Health Organization reported that about one in six laboratory-confirmed bacterial infections globally were resistant to antibiotics in 2023. WHO also estimates that bacterial AMR was associated with more than 4.7 million deaths in 2021. These figures show why the issue is not a distant scientific problem.
But the public conversation needs nuance. Taking an antibiotic when it is not needed can contribute to resistance, but a patient should not stop a prescribed medicine simply because they feel better without speaking to their healthcare professional. The correct medicine, dose and duration depend on the infection and the clinical situation.
A common misunderstanding is that antibiotics treat viruses. They generally do not. Colds and many uncomplicated respiratory infections are caused by viruses, so an antibiotic will not make the virus disappear. Taking an unnecessary antibiotic can expose someone to side effects without providing
benefit.
The solution is not simply “use fewer antibiotics.” It is “use the right antimicrobial at the right time.” That requires better diagnostic tests, good prescribing, infection prevention, vaccination, surveillance and development of new treatments.
Vaccines matter because preventing an infection can prevent the need for an antibiotic in the first place. Good hand hygiene, safe food and water, infection-control practices and appropriate treatment of chronic diseases also reduce the burden of infection.
The future of AMR research is exciting. Scientists are investigating new antibiotics, bacteriophages, antimicrobial peptides, immune-based treatments, microbiome approaches and artificial intelligence for surveillance and drug discovery. None is a magic solution, and many are still being studied.
AMR is also a “One Health” issue. Resistant organisms do not respect the boundaries between hospitals, farms, animals, food systems, wastewater and the environment. WHO’s updated 2026–2036 global
action plan reflects this broader approach.
For readers, the practical rules are straightforward: do not demand antibiotics for every cough or fever;do not share antibiotics; do not use leftover antibiotics from an old illness; take prescribed medicinesexactly as directed unless your clinician tells you otherwise; keep vaccinations up to date where appropriate; and seek medical advice when an infection is severe, persistent or worsening.
The phrase “superbug” sounds like science fiction, but the underlying problem is real. The good news is that resistance is not a reason for panic. It is a reason for smarter medicine.
Every unnecessary antibiotic exposure creates a small opportunity for resistance. Every appropriate prescription, vaccination and infection-prevention measure helps protect the medicines that future patients may need.
The antibiotic age is not necessarily ending. But it is entering an era in which these medicines must be treated as precious medical resources.
Sources and further reading
- WHO, July 16, 2026 – Antimicrobial resistance fact sheet: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance?linkId=663268727
- WHO, May 25, 2026 – Global Action Plan on AMR 2026–2036: https://www.who.int/news/item/25-05-2026-the-world-health-assembly-adopts-updated-global-action-plan-on-antimicrobial-resistance-%282026-2036%29
